MedTrace Logo

Anhydroglucitol in Children With Type 1 Diabetes

NCT05594706 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-05-18

No results posted yet for this study

Summary

The investigators will measure blood levels of 1,5-anhydroglucitol in children with type 1 diabetes and correlate them with parameters related to functional beta-cell mass in diabetic patients. The values will be compared to those obtained in healthy volunteers. Children with newly diagnosed diabetes as well as children with longstanding disease will be included. The aim of the study is to test the validity of 1,5-anhydroglucitol as a novel biomarker of beta-cell mass and function in type 1 diabetes.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

OTHER

Measurement of blood levels of 1,5-anhydroglucitol

Measurement of blood levels of 1,5-anhydroglucitol

Sponsors & Collaborators

  • University of Geneva, Switzerland

    collaborator OTHER

  • University Hospital, Geneva

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-27
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05594706 on ClinicalTrials.gov